| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 06/07/2007 | CA2630438A1 Prodrugs of er.beta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds |
| 06/07/2007 | CA2629587A1 Prodrug er.beta.-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds |
| 06/05/2007 | USRE39678 Meiosis regulating compounds |
| 06/05/2007 | CA2244001C Novel steroid carbamates as potentiating agents |
| 05/30/2007 | EP1790346A2 Use of bile acid or bile salt fatty acid conjugates |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/08/2007 | US7214808 Reacting 3,3-dimethoxy-5alpha, 10alpha-epoxy-estr-9(11)-en-17-one with an active methylene reagent in an inert solvent into an intermediate, regio or stereoselective cleavage of 17-spiroepoxy group |
| 05/02/2007 | EP1778716A1 Process for the preparation of 3-oximino steroids |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 04/24/2007 | US7208613 Treating 17 beta -[(N,N-dimethylcarbamoyl)thio]carbonyl-6 alpha ,9 alpha-difluoro-11-beta -hydroxy-16 alpha-methyl-17-alpha -propionyloxy-3-oxoandrosta-1,4-diene with an alkali metal carbonate-alcohol system and reacting the product with bromofluoromethane |
| 04/24/2007 | CA2322471C S-substituted 11.beta.-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/19/2007 | WO2007025632A3 Nitrooxy derivatives op glucocorticoids |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/18/2007 | EP1187846B1 11beta long-chain substituted estratrienes, method for their production, pharmaceutical preparations containing said 11beta long-chain substituted estratrienes, and their use for producing medicaments |
| 04/17/2007 | US7205288 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
| 04/17/2007 | CA2130803C Novel aminosterol antibiotic |
| 04/12/2007 | WO2007006561A3 Improved crystalline form of the compound a-348441 |
| 04/11/2007 | EP1772462A2 Steroid sulfamates, method for the production and use thereof |
| 04/11/2007 | EP1771462A2 A process for the preparation of 7-alpha-alkylated 19-norsteroids |
| 04/11/2007 | EP1771461A2 Novel 2-substituted estra-1,3,5(10)-trien-17-ones used in the form of inhibitors of 17beta-hydroxysteroiddehydrogenase of type 1 |
| 04/04/2007 | EP1768992A1 Neoglycorandomization and digitoxin analogs |
| 03/27/2007 | US7196075 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 03/27/2007 | US7196074 Hormone replacement therapy |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/20/2007 | US7192942 Wet milling while crystallizing to obtain a primary particle suspension. |
| 03/15/2007 | US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto |
| 03/08/2007 | WO2007025780A2 Aldosterone receptor antagonists |
| 03/08/2007 | WO2007025632A2 Nitrooxy derivatives op glucocorticoids |
| 03/08/2007 | CA2621117A1 Steroids nitrooxyderivatives |
| 03/07/2007 | CN1923841A 7 alpha-substituted 11 alpha-hydroxysteroids and its microbiological production method |
| 03/06/2007 | US7186708 Steroidal compounds |
| 03/06/2007 | CA2163935C 17-(3-imino-2-alkypropenyl)-5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 03/01/2007 | WO2007024338A2 3 -ester prodrugs of ethynylestradiol |
| 03/01/2007 | CA2610475A1 Derivative prodrugs of ethinyl estradiol |
| 02/27/2007 | CA2425849C Angiostatic steroids |
| 02/22/2007 | WO2007022089A2 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products |
| 02/22/2007 | CA2618990A1 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products |
| 02/21/2007 | CN1916013A Pharmaceutical compounds |
| 02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/14/2007 | EP1278763B1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 02/08/2007 | WO2006116309A3 Polymorphic and amorphous salt forms of squalamine dilactate |
| 02/07/2007 | EP1749017A2 Compounds and methods for cytoprotection |
| 02/01/2007 | DE19535572B4 Verfahren zur Herstellung von 17 α-Fluor-steroid-ketonen Process for the preparation of 17 α-fluoro-steroid ketones |
| 01/31/2007 | EP1747231A1 Aminosulphonyl- or aminosulphonylamino-substituted phenyl esters as estriol and estetrol prodrugs |
| 01/31/2007 | EP1747230A1 Aminosulphonyl-or aminosulphonylamino-substituted phenyl esters as estradiol prodrugs |
| 01/31/2007 | EP1747229A1 Steroid prodrugs with androgenic effect |
| 01/31/2007 | CN1906207A Di-steroidal prodrugs of ethinyl estradiol |
| 01/24/2007 | CN1296380C Pharmaceutical compound |
| 01/18/2007 | WO2007008474A2 3 -ester prodrugs of estradiol |
| 01/18/2007 | WO2007006561A2 Improved crystalline form of the compound a-348441 |
| 01/18/2007 | US20070015716 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 01/18/2007 | CA2614048A1 Improved crystalline form of the compound a-348441 |
| 01/18/2007 | CA2610481A1 3-ester prodrugs of estradiol |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/11/2007 | US20070010505 Methods of treating disease states using antiangiogenic agents |
| 01/11/2007 | US20070010504 Polymorphic and amorphous salt forms of squalamine dilactate |
| 01/10/2007 | EP1153029B1 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents |
| 01/09/2007 | US7160871 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 01/09/2007 | US7160866 Isolation of tigogenin pentaglycoside from Chlorophytum nimonii |
| 01/04/2007 | WO2005077968B1 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 01/03/2007 | EP1737880A1 17alpha-fluoro-17beta-hydroximinomethyl steroids, a method for production thereof and pharmaceutical compositions comprising said compounds |
| 01/03/2007 | CN1293090C 9-alpha-substituted estratrienes as selectively active estrogens |
| 01/02/2007 | US7157450 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 01/02/2007 | CA2347346C Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds |
| 01/02/2007 | CA2168850C Estrogenic compounds as anti-mitotic agents |
| 12/27/2006 | CN1886419A Crystalline forms of 3-beta-amino 17-methylene androstane-6-alpha 7-beta-diol hydrochloride |
| 12/19/2006 | CA2149496C 11,21-bisphenyl-19-norpregnane derivatives |
| 12/14/2006 | US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 12/13/2006 | CN1878787A Detection of cholesterol ozonation products |
| 12/12/2006 | US7148213 Steroids with fluoroalkyl groups as antigestation steroids used in gynecological treatment |
| 12/12/2006 | US7148212 Subjecting a supersaturated solution containing a steroid to wet milling while crystallizing, in order to obtain a primary particle suspension. |
| 12/07/2006 | US20060276443 21-substituted progesterone derivatives as new antiprogestational agents |
| 12/07/2006 | US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 12/05/2006 | US7144877 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 11/30/2006 | WO2006125800A1 17β-HSD1 AND STS INHIBITORS |
| 11/30/2006 | US20060270845 16 alpha - and 16 beta -hydroxy-estra-1,3,5(10)-estratrienes, which carry additional substituents on the steroid skeleton and can have one or more additional double bonds in the B-, C- and/or D-rings; higher affinity to estrogen receptors from rat prostates than to estrogen receptors from rat uteri |
| 11/30/2006 | US20060270644 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 11/30/2006 | CA2609726A1 17.beta.-hsd1 and sts inhibitors |
| 11/22/2006 | EP1724254A2 Novel compositions for the delivery of negatively charged molecules |
| 11/22/2006 | EP1551860B1 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 11/22/2006 | EP0970104B1 Steroid sulfamates, method for the production and use thereof |
| 11/22/2006 | CN1867577A Estratriene derivatives |
| 11/16/2006 | WO2005077968A8 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 11/15/2006 | EP1720894A1 Assay for ligands of the ecdysone receptor |
| 11/15/2006 | CN1863559A 化合物 Compound |
| 11/14/2006 | US7135581 For therapy of disease states characterized by abnormal cell mitosis and abnormal angiogenesis |
| 11/07/2006 | US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 11/02/2006 | EP1716166A2 17-methylene- or 17-spiro-cyclopropane 7-substituted estra-1,3,5(10)-triene derivatives with anti-estrogenic activity |
| 11/02/2006 | CA2814247A1 Polymorphic and amorphous salt forms of squalamine dilactate |
| 11/02/2006 | CA2606077A1 Polymorphic and amorphous salt forms of squalamine dilactate |
| 10/26/2006 | US20060241018 Linkers for radiopharmaceutical compounds |
| 10/25/2006 | EP1219632B1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 10/18/2006 | EP1274718B1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
| 10/11/2006 | EP1709061A1 Di-steroidal prodrugs of ethinyl estradiol |
| 10/10/2006 | US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates |
| 10/10/2006 | CA2273343C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 10/05/2006 | US20060224004 Process for preparing ursodeoxycholic acid di-sodium 3,7-disulfate |
| 10/03/2006 | US7115661 Methods and compositions for mitigating pain |